11108 Background: The multidrug resistance (MDR) phenotype reduces the efficacy of various chemotherapies. MDR is linked to the overexpression of ATP-binding cassette (ABC) transporters in cancer cells, including P-glycoprotein (PGP/ABCB1), multidrug resistance protein (MRP1/ABCC1) and breast cancer resistance protein (BCRP/ABCG2). We assessed protein expression patterns of the drug efflux pumps across all tumor types for insight on how to exploit MDR status to circumvent treatment dilemmas. Methods: 51,939 patients molecularly profiled with a commercial multiplatform approach (Caris Life Sciences) were evaluated. Protein expression by IHC was assessed. The Caris Registry was queried for patients in this analysis with available clinical outcomes. Results: Across all tumors profiled (n = 51,939), MRP1 positivity (pos.) was highest at 81% (19935/24682), BCRP at 66% (8849/13409) and PGP the lowest at 23% (11969/51313). GI cancers exhibited the most abundant expression of all three drug pumps (80%, 90%, 53%),...